Skip to content

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05374720
Acronym
CILTUBE
Enrollment
61
Registered
2022-05-16
Start date
2022-11-30
Completion date
2023-10-09
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic Pregnancy, Hysterectomy, Primary Ciliary Dyskinesia, Salpingectomy

Keywords

miscarriage, tubal cilia

Brief summary

Primary Ciliary Dyskinesia associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of mobility of sperm but very little data on the structure and function of tubal cilia in women

Detailed description

Primary Ciliary Dyskinesia (DCP) is a rare genetic disease (1 in 15,000 individuals at birth), which manifests itself in chronic respiratory infections (bronchopneumopathies and rhinosinusitis type) associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of sperm mobility. However, there is very little data in the literature on the structure and function of tubal cilia in women with DCP. Before considering a study of tubal cilia in patients with DCP, it seems necessary to specify in DCP patients or not DCP, the molecular and morphological composition of tubal cilia and to look for ciliary abnormalities in case of GEU

Interventions

PROCEDUREsalpingectomy

Removal of one of the fallopian tubes.

PROCEDUREhysterectomy

remove the uterus, whole or only part. It may also involve the removal of the cervix, ovaries, fallopian tubes and other surrounding structures.

Sponsors

Centre Hospitalier Intercommunal Creteil
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with scheduled salpingectomy (Ectopic pregnancy, hysterectomy for prolapsus, adenomyosis or myomectomy) * Major patients ( \>18 years)

Exclusion criteria

* Patient not willing to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
morphological of tubal ciliathrough study completion, an average of 6 week after surgeryMolecular compositor of tubal ciliar by immunofluorescence study of 14 proteins in vivo and in vitro (tissue cells from patient fallopian tubes)
Molecular difference in tubal cilia between patients with or without GEU salpingectomythrough study completion, an average of 6 week after surgerycompares molecular compositor of tubal ciliar by immunofluorecence study of 14 proteins in vivo and in vitro between patients with or without GEU salpingectomy
molecular tubal ciliathrough study completion, an average of 6 week after surgeryUltrastructure morphology of tubal cell cilia by electron microscopy
functional composition of tubal cell by video microscopythrough study completion, an average of 6 week after surgeryamplitude of moment by video microscopy

Countries

France

Contacts

PRINCIPAL_INVESTIGATORRana i MITRI-FRANGIEH

Centre Hospitalier Intercommunal Créteil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026